Investigation raises serious questions about the harm-benefit balance of Rexulti; the Decision may reverse efforts to reduce the use of antipsychotics in US care homes....
from SciTechDaily https://ift.tt/cH6Svj1
FDA’s Shocking Approval: Rexulti Fast-Tracked Despite Deadly Risks
October 06, 2023
0
Tags